Biofrontera (BFRI) Net Margin (2020 - 2025)
Biofrontera (BFRI) recorded quarterly Net Margin of 32.98% in Q4 2025, up 134.66% quarter-over-quarter from 95.15% in Q3 2025, and up 4410.0% on a YoY basis from 0.73% in Q4 2024.
Biofrontera (BFRI) Net Margin (2020 - 2025) Analysis & Trends
Biofrontera's Net Margin history runs 6 years deep, the most recent figure standing at 32.98% for Q4 2025.
- In Q4 2025, Net Margin rose 4410.0% year-over-year to 32.98%; the TTM figure through Dec 2025 stood at 25.26% (up 2232.0% YoY), while the FY2025 annual figure was 25.26%, up 2232.0% from the prior year.
- Net Margin was 32.98% for Q4 2025 at Biofrontera, up from 95.15% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 57.03% in Q1 2022 to a low of 369.45% in Q3 2021.
- Historically, Net Margin has averaged 69.23% across 5 years, with a median of 60.95% in 2021.
- The sharpest annual moves came in 2021 and 2022: Net Margin plunged 27766 bps in 2021, then surged 31008 bps in 2022.
- A 5-year view of Net Margin shows it stood at 158.21% in 2021, then soared by 83 bps to 27.45% in 2022, then soared by 221 bps to 33.28% in 2023, then sank by 133 bps to 11.12% in 2024, then jumped by 397 bps to 32.98% in 2025.
- The last three Net Margin figures came in at 32.98% (Q4 2025), 95.15% (Q3 2025), and 58.96% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | 32.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.98% |
| Sep 30, 2025 | -95.15% |
| Jun 30, 2025 | -58.96% |
| Mar 31, 2025 | -48.94% |
| Dec 31, 2024 | -11.12% |
| Sep 30, 2024 | -62.91% |
| Jun 30, 2024 | -3.28% |
| Mar 31, 2024 | -131.91% |
| Dec 31, 2023 | 33.28% |
| Sep 30, 2023 | -71.29% |
| Jun 30, 2023 | -168.21% |
| Mar 31, 2023 | -85.63% |
| Dec 31, 2022 | -27.45% |
| Sep 30, 2022 | -59.37% |
| Jun 30, 2022 | -19.07% |
| Mar 31, 2022 | 57.03% |
| Dec 31, 2021 | -158.21% |
| Sep 30, 2021 | -369.45% |
| Jun 30, 2021 | -62.53% |
| Mar 31, 2021 | -74.49% |